Log in or Sign up for Free to view tailored content for your specialty!
Chronic Kidney Disease News
Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma
NASHVILLE, Tenn. — Zanzalintinib monotherapy showed promising antitumor activity among patients with previously treated clear cell renal cell carcinoma, according to findings presented at International Kidney Cancer Symposium: North America.
Researchers develop all-cause mortality risk prediction model for adults with advanced CKD
PHILADELPHIA — Researchers presented data at ASN Kidney Week from a prediction model that can forecast all-cause mortality in adults with advanced chronic kidney disease.
Log in or Sign up for Free to view tailored content for your specialty!
Diabetes linked to poorer survival after nephrectomy for renal cell carcinoma
NASHVILLE, Tenn. — Diabetes appeared linked to shorter survival among patients who underwent nephrectomy for renal cell carcinoma, according to study results presented at International Kidney Cancer Symposium: North America.
Study reviews survival timeline in patients who end dialysis
PHILADELPHIA — Patients with kidney disease who opted to withdraw from dialysis typically survived around 1 week, according to data presented at ASN Kidney Week.
After organ donation, kidney stone formers saw fewer cases of nephrolithiasis
PHILADELPHIA — The incidence for a kidney stone event was lower in a cohort of individuals 1 year after donating a kidney compared to individuals who were turned down for donation, data from ASN Kidney Week showed.
Study: Higher medication nonadherence for Black vs. white adults with glomerular disease
PHILADELPHIA — Black adults with glomerular diseases showed more medication nonadherence compared with white adults, according to study results presented at ASN Kidney Week, here.
Lower rates of access thrombosis for patients with CKD who receive daprodustat vs. EPO
PHILADELPHIA — Patients with chronic kidney disease on dialysis who received daprodustat had fewer vascular access thrombosis events compared with patients who had erythropoiesis-stimulating agents, according to data presented here.
Protection of peer mentorship to reduce hospitalization, ED visits varies by population
PHILADELPHIA — The protective effect of peer mentorship to reduce hospitalizations and ED visits in patients on maintenance dialysis may be population-specific, according to a study presented at ASN Kidney Week.
VIDEO: Sparsentan well-tolerated, demonstrated sustained anti-proteinuria effects
PHILADELPHIA — Sparsentan was shown to be well-tolerated and demonstrated sustained anti-proteinuria effects at the final analysis of 110 weeks, according to research presented at ASN Kidney Week.
Novel aldosterone synthase inhibitor may aid patients with CKD
PHILADELPHIA — A novel aldosterone synthase inhibitor, BI 690517, was well-tolerated and reduced urine albumin-to-creatinine ratio in patients with chronic kidney disease, according to a presentation at ASN Kidney Week.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read